ASP Isotopes CEO logs stock sales and large grant
ASP Isotopes Inc. Chairman and CEO Paul Elliot Mann reported both share sales and a new equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ASP Isotopes Inc. Chairman and CEO Paul Elliot Mann reported both share sales and a new equity award. He sold a total of 251,275 shares of common stock in three open-market transactions at weighted average prices of $7.76, $7.88, and $8.29 per share. According to the disclosure, these were "sell to cover" trades under a Rule 10b5-1 plan to cover tax withholding on quarterly vesting of a restricted stock award. Mann also received a grant of 2,233,555 shares of common stock under his employment agreement, which will vest in four equal installments over a one-year period beginning on March 1, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,233,555 | $0.00 | $0.00 |
| Sale | Common Stock | 83,758 | $7.88 | $660K |
| Sale | Common Stock | 83,758 | $8.29 | $694K |
| Sale | Common Stock | 83,759 | $7.76 | $650K |
Footnotes (5)
- F1. This award of common stock was issued to the reporting person pursuant to his Employment Agreement dated October 4, 2021, as amended on December 20, 2022 and April 5, 2024, and shall vest (subject to compliance with applicable vesting conditions) in four equal installments over a one-year period beginning on March 1, 2026.
- F2. Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $8.14, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $8.52, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.53 to $8.13, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
sell to cover financial
restricted stock award financial
weighted average price financial
vesting conditions financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ASP Isotopes (ASPI) report for Paul Elliot Mann?
What equity award did ASP Isotopes (ASPI) grant to its CEO in this Form 4?
How will the new ASP Isotopes (ASPI) stock grant to the CEO vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.